XML 42 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Incentive Plan (Tables)
9 Months Ended
Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of information regarding outstanding Stock Options and Incentive Warrants and the changes during the fiscal year
The following summary presents information regarding outstanding Stock Options as of March 31, 2017, and the changes during the period:
 
Number of Stock
Options
 
Weighted Average
Exercise Price
 
Aggregate
Intrinsic Value
(1)
 
Weighted
Average
Remaining
Contractual
Term (in
years)
Stock Options outstanding at July 1, 2016
35,231

 
$
2.19

 
 

 
 
Stock Options outstanding at March 31, 2017
35,231

 
$
2.19

 
$
204,692

 
0.4
Vested and exercisable at March 31, 2017
35,231

 
$
2.19

 
$
204,692

 
0.4
(1) Based upon the difference between the market price of our common stock on the last trading date of the period ($8.00 as of March 31, 2017) and the Stock Option exercise price of in-the-money Stock Options.
Schedule of Restricted Stock transactions
Unvested Contingent Restricted Stock awards at March 31, 2017 consisted of the following:

Number of
Contingent
Restricted
Shares
 
Weighted
Average
Grant-Date
Fair Value
Performance-based awards
39,403

 
$
7.02

Market-based awards
73,867

 
3.37

Unvested contingent shares at March 31, 2017
113,270

 
$
4.64

Unvested Restricted Stock awards at March 31, 2017 consisted of the following:

Number of
Restricted
Shares
 
Weighted
Average
Grant-Date
Fair Value
Service-based awards
219,940

 
$
7.08

Performance-based awards
54,475

 
5.67

Market-based awards
119,227

 
4.97

Unvested Restricted Stock at March 31, 2017
393,642

 
$
6.25

Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Restricted Stock transactions
The following table sets forth the Restricted Stock transactions for the nine months ended March 31, 2017:
 
Number of
Restricted
Shares
 
Weighted
Average
Grant-Date
Fair Value
 
Unamortized Compensation Expense at March 31, 2017
 
Weighted Average Remaining Amortization Period (Years)
Unvested at July 1, 2016
406,848

 
$
6.74

 
 
 
 
Service-based shares granted
86,563

 
7.02

 
 
 
 
Performance-based shares granted
54,475

 
5.67

 
 
 
 
Market-based shares granted
54,475

 
5.44

 
 
 
 
Vested
(208,719
)
 
7.17

 
 
 
 
Unvested Restricted Stock at March 31, 2017
393,642

 
$
6.25

 
$
1,923,545

 
2.2


Contingent Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Restricted Stock transactions
The following table sets forth Contingent Restricted Stock transactions for the nine months ended March 31, 2017:
 
Number of
Contingent
Restricted
Shares
 
Weighted
Average
Grant-Date
Fair Value
 
Unamortized Compensation Expense at March 31, 2017 (1)
 
Weighted Average Remaining Amortization Period (Years)
Unvested at July 1, 2016
91,172

 
$
5.21

 
 
 
 
Performance-based awards granted
27,237

 
5.67

 
 
 
 
Market-based awards granted
27,237

 
3.42

 
 
 
 
Vested
(32,376
)
 
6.09

 
 
 
 
Unvested contingent shares at March 31, 2017
113,270

 
$
4.64

 
$
149,015

 
2.2
(1) Excludes $276,702 of potential future compensation expense for contingent performance-based awards for which vesting is not considered probable at this time for accounting purposes.